drugset / Trial / NCT03078530

Probiotic (Visbiome) for Gulf War Illness

NCT03078530

RandomizedParallel-groupTriple-blindTreatment

Summary

The overall objective is to determine whether Visbiome will improve 1. intestinal symptoms of Irritable Bowel Syndrome (IBS) and 2. non-intestinal symptoms (fatigue, joint pain, insomnia, general stiffness and headache) associated with IBS. All of these symptoms are part of the Gulf War (GW) illness.

Timeline

Start
2013-09-13
Primary completion
2018-05-31
Completion
2018-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject VSL#3 Other / unclassified
Subject Visbiome Other / unclassified

Indications